Epinephrine (generic), Epipen Newswire (Page 4)

Epinephrine (generic), Epipen Newswire (Page 4)

Comprehensive Real-Time News Feed for Epinephrine (generic), Epipen. (Page 4)

Results 61 - 80 of 1,470 in Epinephrine (generic), Epipen

  1. UPDATE 1-Adamis wins U.S. approval to sell EpiPen rival, shares soarRead the original story w/Photo

    Thursday Jun 15 | Reuters

    Adamis Pharmaceuticals Corp said on Thursday it received U.S. approval for its emergency epinephrine syringes to treat severe allergic reactions that it intends to be a lower cost rival to Mylan NV's widely used EpiPen, sending its shares up more than 50 percent. The company said it was looking for a marketing partner and would set a price for the product before its launch sometime in the second half of this year.

    Comment?

  2. Adamis Obtains FDA Approval for Epinephrine TreatmentRead the original story w/Photo

    Thursday Jun 15 | Wall Street Journal

    Adamis Pharmaceuticals Corp. said Thursday that federal regulators have given it a green light to produce an emergency injection treatment for allergic reactions, providing a potential competitor to Mylan NV's EpiPen.

    Comment?

  3. BRIEF-Adamis Pharmaceuticals gets FDA approval for co's epinephrine pre-filled syringeRead the original story w/Photo

    Thursday Jun 15 | Reuters

    * Mobile Mini Inc - on June 13,co, Mark Funk, CFO of co, amended terms of previously disclosed transition agreement and mutual release, dated April 6

    Comment?

  4. UPDATE 1-China's U.S. bond holdings grew in April, still behind JapanRead the original story w/Photo

    Thursday Jun 15 | Reuters

    China increased its ownership of U.S. Treasuries for the third straight month in April to its highest in six months but still ranked behind Japan, which remained the United States' biggest creditor, U.S. Treasury Department data showed on Thursday. China's holding of U.S. government debt grew to $1.092 trillion in April from $1.088 trillion in March.

    Comment?

  5. Adamis Pharma Stock Skyrockets After Rival EpiPen Product Gets FDA ApprovalRead the original story w/Photo

    Thursday Jun 15 | Fox News

    Adamis Pharmaceuticals Corp. shares soared 53% to a one-year high Thursday after the company's allergic reaction treatment, intended as a rival to Mylan's EpiPen , was approved by the Food and Drug Administration. Symjepi includes two syringes pre-filled with a dose each of epinephrine, which is used to treat allergic reactions.

    Comment?

  6. Adamis gets U.S. approval to sell EpiPen rival, shares soarRead the original story w/Photo

    Thursday Jun 15 | Reuters

    Adamis Pharmaceuticals on Thursday said it received U.S. approval for its emergency epinephrine syringes to treat severe allergic reactions that would compete with Mylan's widely used EpiPen, sending its shares up 50 percent. Adamis said the Food and Drug Administration also approved the brand name Symjepi.

    Comment?

  7. American Medical Association urges drug companies to advertise pricesRead the original story w/Photo

    Thursday Jun 15 | Chicago Tribune

    In this July 8, 2016, file photo, a pharmacist holds a package of EpiPen epinephrine auto-injectors, a Mylan product, in Sacramento, Calif. After uproar over price increases for products like the EpiPen, the American Medical Association is calling on drug manufacturers to include the suggested retail prices of drugs in consumer advertisements.

    Comment?

  8. Adamis Pharmaceuticals Receives FDA Approval for Its Epinephrine Pre-Filled SyringeRead the original story w/Photo

    Thursday Jun 15 | GlobeNewswire

    Adamis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration has approved Adamis' EPINEPHRINE INJECTION, USP, 1:1000 for the emergency treatment of allergic reactions including anaphylaxis. The FDA has also approved the PFS trade name of Symjepia .

    Comment?

  9. When Food Makes You SickRead the original story

    Thursday Jun 15 | Health News Digest

    Food allergies can be a matter of life or death. If you suffer from a food allergy or know someone who does, it's vitally important to know what to do - and what not to do - if a reaction occurs.

    Comment?

  10. Drug allergies: What you need to knowRead the original story w/Photo

    Thursday Jun 15 | Medical News Today

    Drug allergies cause specific allergic reactions to drugs or medications. They are different from side effects, and these differences need to be understood.

    Comment?

  11. No gender difference in stress as a risk factor for coronary heart diseaseRead the original story w/Photo

    Wednesday Jun 14 | Science Blog

    In a new study, UCLA researchers hypothesized that simple biomarkers - urinary stress hormones dopamine, epinephrine and norepinephrine, and cortisol - would be associated with more calcium buildup in the coronary arteries, which indicates the presence of coronary heart disease, and that this effect would be stronger in women than in men. However, the researchers found that this relationship was actually similar in women and men: Although women had higher average levels of urine stress hormones than men, the association between stress and having asymptomatic coronary heart disease as measured by coronary calcium was similar in both genders.

    Comment?

  12. 'I knew that it was working': Woman describes efforts to save jogger's lifeRead the original story w/Photo

    Thursday Jun 15 | CBC News

    An Ottawa paramedic vehicle is parked next to a City of Ottawa truck at Neil Nesbitt Park in Barrhaven on Wednesday morning, where a jogger collapsed and bystanders worked to help save him. Adele Gawley was driving home from Starbucks in Barrhaven Wednesday morning when, while passing Neill Nesbitt Park, she saw a group of workers in orange safety vests huddled over the body of a man on the ground.

    Comment?

  13. Scapegoating Businesses for Bad Government Policy: New at ReasonRead the original story w/Photo

    Thursday Jun 15 | Quebec Chronicle-Telegraph

    There's a disturbing and counterproductive tendency to scapegoat individual businesses for responding predictably to conditions established by the choices politicians make. A recent example is a replay of last year's attacks on Mylan, which manufactures the popular epinephrine auto-injector EpiPen and is still apparently being blamed for problems in the health care industry that were created long ago by bad government policy and sustained over the years thanks to political cowardice.

    Comment?

  14. Can stress really make you lose your teeth?Read the original story w/Photo

    Wednesday Jun 14 | Manawatu Evening Standard

    It wasn't a fight or a fall that made Demi Moore lose her two front teeth. Rather, the actress told Jimmy Fallon on Monday's The Tonight Show, that stress was to blame.

    Comment?

  15. Adamis showing volatility ahead of FDA decision on generic EpiPenRead the original story w/Photo

    Wednesday Jun 14 | Seeking Alpha

    Thinly traded micro cap Adamis Pharmaceuticals had an up-and-down day ahead of tomorrow's expected FDA decision on its generic version of Mylan's emergency allergy med EpiPen . Shares were down early, clawed back into the green, but then could not hold on to the gain.

    Comment?

  16. What to Do About Summer AllergiesRead the original story w/Photo

    Tuesday Jun 6 | US News & World Report

    Summer is for spending time outside, but if you suffer from a summertime allergy , the outdoors may not be your friend. Let's look at some of the common summer allergies and what you can do about them.

    Comment?

  17. So it sure looks as if, contrary to the headline, the outcry over EpiPen prices has made them lower.Read the original story

    Monday Jun 5 | PressReleasePoint

    That isn't what nearly 90 percent of EpiPen buyers have paid less than $100 per box because of insurance, discounts or coupons says, right? Not to trash the article or manufacturers but because of insurance and the big thumb of FedGov, we can't know the answer from the minimal information provided, right? We must all allow our obvious betters in the FDA determine what a fair prices is because we're all so stupid and don't know what is good for us. Just look how the FCC looked after all us little people when it came to selling and marketing the cell phone.

    Comment?

  18. The chairman of EpiPen maker reportedly gave everyone the fingerRead the original story w/Photo

    Monday Jun 5 | SFGate

    This Oct. 10, 2013, file photo, shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. Numerous drug companies have been criticized for the increased prices of some medications in the past few years.

    Comment?

  19. Mylan chairman: Drug pricing critics ought to go copulate with themselvesRead the original story w/Photo

    Monday Jun 5 | Ars Technica

    Some pharmaceutical companies are troubled by stratospheric drug prices. Several have vowed to limit price hikes, for instance.

    Comment?

  20. Berman DeValerio Announces EpiPen Purchasers Accuse Pharmacy Benefit...Read the original story

    Monday Jun 5 | Customer Interaction Solutions

    A group of EpiPen purchasers have sued their pharmacy benefit managers, known as PBMs, in federal court in Minneapolis. In a lawsuit filed by Berman DeValerio, the EpiPen purchasers claim the PBMs-Express Scripts, CVS Health, and Prime Therapeutics-bear responsibility for the massive increase in the amounts EpiPen purchasers paid out-of-pocket for EpiPen.

    Comment?